YURiA-PHARM products - Georgia

Category

Filter

Novelty

Kvanadex

Kvanadex is a modern sedative from Yuria-Pharm! Kvanadex provides the optimal level of sedation when: regional anesthesia oxygenation procedure performed mechanical ventilation treatment and prevention of delirium With: The patient – calm ...

Xavron

XAVRON - ischemic cascade blocker for the empirical therapy of acute ischemic stroke and transient ischemic attack.

How supplied:

injection solution 1,5 mg/ml, ampoules 20 ml №2 and №10.

Leflocin®

The gold standard of empiric antibiotic therapy. Fluoroquinolones safety standard.

Tivortin®

Indispensable nitric oxide donor. Active substance formulated into Tivortin® - L-arginine amino acid — is the only substrate for nitric oxide (NO) synthesis in humans. Tivortin® aspartate is a potent vasodilator, vascular tone regulator.

Ingamist®

The drug liquefies the mucus (mucolytics) ans is intended for inhalation, intramuscular and intravenous administration. Acetylcysteine.

How supplied:

Solution for injection, 100 mg/ml, 3 ml in ampoules No. 10.

Nebutamol®

Inhaled quick-relief bronchodilator. Salbutamol.

How supplied:

2 ml single-dose containers, 10 or 40 pcs per pack.

Yunorm®

Yunorm® is a strong antiemetic agent.

How supplied:

Yunorm solution, 2 mg/ml, closed preparation system 8 mg. Yunorm solution, 2 mg/ml, 2 ml No.5 ampoules. Yunorm solution, 2 mg/ml, 4 ml No.5 ampoules. Yunorm syrup, 4 mg/5 ml, 50 ml.

Tivortin® aspartate

Indispensable nitric oxide donor. Active substance formulated into Tivortin® ‒ L-arginine amino acid , is essential for children and the elderly, as after 50 years its synthesis is gradually reducing.

Sufer®

Sufer® is an intravenous iron preparation for rapid clinical and haematological correction of iron deficiency.

How supplied:

100 mg (5 ml) ampoules No.5; 200 mg (10 ml) vial, special solvent included — 0.9 % NaCl-Soluven 100 ml.

Soda-Buffer® 4,2 mg/ml

The only buffered sodium bicarbonate solution in Ukraine. Soda-Buffer® is indicated for treatment of diseases and pathological conditions accompanied by metabolic acidosis.

Sangera®

Sangera® is a next generation haemostatic, 26 times more active than aminocaproic acid and 10 times more effective than ethamsylate.

How supplied:

5 ml ampoule. 10 ml vial. 10 ml vial. 1 vial + 1 container with solvent agent (sodium chloride-Soluven, 9 mg/ml, 100 ml).

Rheosorbilact®

Number one infusion therapy preparation. This is one of the most balanced solutions: rational combination of components complementing and potentiating each other’s action; the product provides comprehensive pharmacological effects.
  • 1
  • 2